We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Recombinant human thrombopoietin promotes hematopoietic reconstruction after severe whole body irradiation.
- Authors
Wang, Chao; Zhang, Bowen; Wang, Sihan; Zhang, Jing; Liu, Yiming; Wang, Jingxue; Fan, Zeng; Lv, Yang; Zhang, Xiuyuan; He, Lijuan; Chen, Lin; Xia, Huanzhang; Li, Yanhua; Pei, Xuetao
- Abstract
Recombinant human thrombopoietin (rHuTPO) is a drug that is used clinically to promote megakaryocyte and platelet generation. Here, we report the mitigative effect of rHuTPO (administered after exposure) against severe whole body irradiation in mice. Injection of rHuTPO for 14 consecutive days following exposure significantly improved the survival rate of lethally irradiated mice. RHuTPO treatment notably increased bone marrow cell density and LSK cell numbers in the mice after sub-lethal irradiation primarily by promoting residual HSC proliferation. In lethally irradiated mice with hematopoietic cell transplantation, rHuTPO treatment increased the survival rate and enhanced hematopoietic cell engraftment compared with the placebo treatment. Our observations indicate that recombinant human TPO might have a therapeutic role in promoting hematopoietic reconstitution and HSC engraftment.
- Subjects
THROMBOPOIETIN; RECOMBINANT proteins; BONE marrow; CELL proliferation; HEMATOPOIETIC stem cell transplantation
- Publication
Scientific Reports, 2015, p12993
- ISSN
2045-2322
- Publication type
Article
- DOI
10.1038/srep12993